Aspirin for primary prevention of cardiovascular disease in diabetes

J Diabetes Investig. 2019 Jul;10(4):899-901. doi: 10.1111/jdi.13006. Epub 2019 Feb 8.

Authors

Ying Xing¹, Kathryn Cb Tan²

Affiliations

¹ Department of Endocrinology and Metabolic Disease, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.
² Department of Medicine, University of Hong Kong, Hong Kong SAR.

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Aspirin / therapeutic use*
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / prevention & control*
Diabetes Mellitus / physiopathology*
Humans
Incidence
Primary Prevention
Prognosis

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin